Drugs Panel Proposes Curbs on OTC Medicines to Prevent Misuse

India's premier drug advisory panel is in the process of weighing a proposal to limit the over-the-counter sale of frequently used self-medication drugs in a bid to curb abuse and guarantee patient safety, sources familiar with the issue revealed...

ICMR Calls for Targeted Ban on Popular Painkiller Over Safety Concerns

The Indian Council of Medical Research (ICMR) has instructed a ban on all formulations of the broadly used painkiller Nimesulide above 100 mg. The proposal, which aims at patients under 18 and those aged 60 and above, underscores deep safety concerns

Indian Stem Cell Sector Gaining Momentum with Govt Support

Rapid advancements in stem cell therapy are seen in India based on government support, private funding and a strong academic research ecosystem. Dr. Mrinalini Chaturvedi, Medical Director of Cryoviva Life Sciences, says ...

Vgenomics, Meril Genomics Partner to Transform Precision Medicine in India

Meril Genomics, a reputable diagnostics and molecular biology provider, and Vgenomics, a leading precision health firm, have announced a ground-breaking collaboration to supply hospitals and research facilities across India with complementing....

Zydus Medtech, Braile Biomedica announce global pact to commercialise TAVI

Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited specializing in medical technology development, has entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda...

Indian Pharma Targets New Markets to Offset US Sales Decline

To protect their growth in turbidity, Indian pharmaceutical companies, especially the smaller and mid-sized players, are now swinging their attention to...

Fortis Launches Institute of Genomic Medicine to Transform Healthcare

Fortis Healthcare announced that would be inaugurating the Fortis Institute of Genomic Medicine, a high-tech setup aimed at rejuvenating patient care with the facility's goal to settle...

India Revises Pharma Import Monitoring Fees to Boost Compliance

The Foreign Trade Policy (FTP) 2023's Appendix 2K has been updated by the Directorate General of Foreign Trade (DGFT), requiring pharmaceutical imports and exports to pay a registration fee through the Import Monitoring System (IMS). The objective o

Venus Remedies' Polymyxin B Gets US FDA QIDP Designation

The United States Food and Drug Administration (US FDA) has designated Venus Remedies Limited, a Panchkula-based pharmaceutical company that specializes in critical care injectables, as a Qualified Infectious Disease Product (QIDP) for the....

Medical Device Makers in India Push for Safeguard Duty on Imports

Amidst the ongoing difficulties in global commerce brought on by US-China tariffs, India's medical equipment industry is seeing a startling increase in imports. Citing the possibility of serious harm to the domestic economy, the Association of Indian